問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
張兆祥
下載
2025-11-01 - 2030-12-31
Condition/Disease
Prostatic Neoplasms, Castration-Resistant
Test Drug
Intravenous infusion solution Intravenous infusion solution Tablets
Participate Sites5Sites
Recruiting5Sites
2021-01-04 - 2026-04-30
Participate Sites3Sites
Recruiting1Sites
Terminated2Sites
2020-07-22 - 2027-11-10
Participate Sites7Sites
Recruiting7Sites
2019-01-01 - 2027-05-27
Participate Sites9Sites
Recruiting9Sites
2021-01-01 - 2029-10-31
2023-03-20 - 2030-06-30
Participate Sites6Sites
Recruiting6Sites
2019-07-22 - 2030-05-31
2019-11-01 - 2024-05-13
Participate Sites13Sites
Recruiting13Sites
2020-06-01 - 2027-11-06
Participate Sites8Sites
Recruiting8Sites
2018-09-26 - 2022-05-18
Division of Hematology & Oncology
全部
